Han Wen Chen
Direttore/Membro del Consiglio presso SHENWAN HONGYUAN GROUP CO., LTD.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Rong Yi Fang | M | 58 |
Xiamen University
| 11 anni |
| Jie Qi | M | 58 | - | |
| Wan Fu Zhou | M | 58 | 4 anni | |
| Zhao Bin He | M | 56 | 7 anni | |
| Liang Xu | M | 49 | 9 anni | |
| Xiao Jian Wang | M | 51 |
Xiamen University
Xiamen International Bank Co., Ltd.
 Xiamen International Bank Co., Ltd. Major BanksFinance Xiamen International Bank Co., Ltd. engages in the provision of commercial banking services. Its business scopes include personal and corporate deposits, loans, bonds, settlements, interbank borrowing, foreign exchanges, insurance, and credit services. The company was founded on August 31, 1985 and is headquartered in Shenzhen, China. | 11 anni |
| Yong Qing Cheng | M | 62 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
 Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 32 anni |
| Zheng Yu Yan | M | 63 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 25 anni |
| Xu Han | M | 53 | - | |
| Zhi Ren Lu | M | 60 | 3 anni | |
| De Qi Ren | M | 61 | 6 anni | |
| Xing She Guan | M | 58 |
Xiamen University
| 8 anni |
| Qiang Wang | M | 52 | 4 anni | |
| Siuman Yeung | F | 61 | 4 anni | |
| Wei Li | M | 51 | 11 anni | |
| Ming Jun Xu | M | 61 | 6 anni | |
| Xiao Yu Zhang | M | 55 | 11 anni | |
| Kwok Keung Yuen | M | 60 | 4 anni | |
| Lei Zhao | M | 50 | 3 anni | |
| Jian Bin Wu | M | 61 | 7 anni | |
| Quan Sheng Ren | F | 56 | 4 anni | |
| Qi Lan | M | 68 | 4 anni | |
| Xiao Chun Liu | M | 65 | 4 anni | |
| Bao Qun Fan | M | 52 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 3 anni |
| Jin Yi Liu | M | 55 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 25 anni |
| Jia Cao | M | 40 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 10 anni |
| Jun Yang Yu | M | 49 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 24 anni |
| Xiao Lei Liu | M | 50 | 6 anni | |
| Feng Zhang | M | 48 | 11 anni | |
| Jiuyong Yin | M | 57 | 5 anni | |
| Bin Qian | M | 52 | 3 anni | |
| Ji Ye Mao | M | 61 | 2 anni | |
| Tin Chak Wong | M | 60 | 1 anni | |
| Jing Gang Song | M | 50 | 2 anni | |
| Fu Ning Hou | M | 60 | 8 anni | |
| Zhi Qing Li | M | 49 | 1 anni | |
| Jing Dong Liu | M | 56 | 7 anni | |
| Xiang Dong Zhang | M | 67 | 4 anni | |
| Hao Yi Cai | M | 70 | 6 anni | |
| Jun Ma | M | 61 | 2 anni | |
| Cong Lai Fan | M | 62 | 4 anni | |
| Chang Qi Wu | M | 69 | 3 anni | |
| Fu Rong Zhang | M | 71 |
Financial Accounting Society of China
| - |
| Yi Yi Dai | M | 57 |
Xiamen University
School of Management Xiamen University
| 24 anni |
| Chong En Bai | M | 61 | 4 anni | |
| Lei Shi | M | 66 | 5 anni | |
| Xiao Hui Li | M | 57 | 4 anni | |
| Jiarong You | M | 70 |
China Audit Society
| - |
| Lincoln Zhang | M | 52 | - | |
| Guo Hua Chi | M | 50 |
Xiamen University
Nanjing Audit University
| 11 anni |
| De Ming Zhao | M | 58 |
Xiamen University
| 4 anni |
| Yan Meng | M | 69 |
Financial Accounting Society of China
China Audit Society
| - |
| Chao Xiong Tang | M | 56 | 2 anni | |
| Jian Fang Ye | M | 58 | 7 anni | |
| Hao Huang | M | 50 | 4 anni | |
| Qing Hui Cai | M | 50 |
Xiamen University
| 19 anni |
| Yi Chien Liao | M | 51 | 3 anni | |
| Rong Xie | M | 71 |
China Audit Society
| - |
| Guo Xin Mu | M | 57 | 2 anni | |
| Cheng Hao | M | - | 3 anni | |
| Li Min Zhang | M | 69 |
China Audit Society
| - |
| Da Hai Xu | M | 62 |
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | 25 anni |
| Shuang Li | M | 80 |
China Audit Society
| - |
| Ye Lin Li | M | 70 |
China Audit Society
| - |
| Li Yan Wang | M | 67 |
China Audit Society
| - |
| Pei Yong Gao | M | 65 |
China Audit Society
| - |
| Hua Lin | M | - | 3 anni | |
| Long Cheng Li | M | 59 | 4 anni | |
| Dong Lin Xia | M | 63 |
China Audit Society
| - |
| Lei Fu | M | 73 |
China Audit Society
| - |
| Jian Xin Geng | M | 70 |
China Audit Society
| - |
| Xiaopeng Luo | M | 49 | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Ben Xi Ding | M | 69 | 11 anni | |
| Wei Dong Hou | M | 65 | 18 anni | |
| Quanxun Zhang | M | 50 |
Xiamen University
| 15 anni |
| Hu Cheng | M | 47 |
Xiamen University
| 11 anni |
| Xiao Ming Chu | M | 62 | - | |
| Wai Chu Tam | M | 78 | 3 anni | |
| Xing Zhong Wang | M | 56 | 3 anni | |
| Ji Ping Yang | M | 53 | 2 anni | |
| Xiangxi Wang | M | 61 | 3 anni | |
| You Zhi Xiang | M | 60 |
Xiamen University
| 7 anni |
| Ying Jie Zhong | F | 56 | 3 anni | |
| Wei Wu | M | 54 | 6 anni | |
| Shu Ye | M | 52 |
Xiamen University
| 6 anni |
| Da Chen | M | 41 |
Xiamen University
| 8 anni |
| Chen Li Liu | M | 43 |
Xiamen University
| 7 anni |
| Guang Huang | M | 61 |
Xiamen University
| 5 anni |
| Bo Jiang | M | 69 | - | |
| Jian Li | M | 71 | 6 anni | |
| Jin Ping Shi | M | 46 |
Xiamen University
| 5 anni |
| Jie Liu | M | 52 |
Xiamen University
| 5 anni |
| Su Ping Peng | M | 65 | 2 anni | |
| Xiang Hua You | M | 60 |
Xiamen University
| 5 anni |
| Qing Huang | M | 59 | 19 anni | |
| Ya Rong Du | M | 60 | 24 anni | |
| Feng Chen | M | 52 |
Xiamen University
| 6 anni |
| Yi Cheng Ji | M | 65 |
Xiamen University
| 7 anni |
| Li Liu | M | 69 | 6 anni | |
| Zhong Lin | M | 55 |
Xiamen University
| 6 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Cina | 100 | 100.00% |
| Stati Uniti | 0 | -.--% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Han Wen Chen
- Contatti personali
